Sorrento Therapeutics Inc (SRNE)
0.038
0.00 (0.00%)
USD |
OTCM |
Apr 16, 13:08
Sorrento Therapeutics Profit Margin (Quarterly): -633.7% for June 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -633.7% |
| March 31, 2023 | -859.1% |
| December 31, 2022 | -1.43K% |
| September 30, 2022 | -514.8% |
| June 30, 2022 | -1.91K% |
| March 31, 2022 | -222.0% |
| December 31, 2021 | -1.10K% |
| September 30, 2021 | -993.2% |
| June 30, 2021 | -1.23K% |
| March 31, 2021 | 17.61% |
| December 31, 2020 | -621.5% |
| September 30, 2020 | -714.9% |
| June 30, 2020 | -863.1% |
| March 31, 2020 | -844.4% |
| December 31, 2019 | -482.0% |
| September 30, 2019 | -1.11K% |
| June 30, 2019 | -876.4% |
| March 31, 2019 | -1.76K% |
| December 31, 2018 | -718.4% |
| September 30, 2018 | -1.15K% |
| June 30, 2018 | -1.89K% |
| March 31, 2018 | -521.5% |
| December 31, 2017 | |
| September 30, 2017 | -1.69% |
| June 30, 2017 | -304.1% |
| Date | Value |
|---|---|
| March 31, 2017 | -473.2% |
| December 31, 2016 | -444.3% |
| September 30, 2016 | |
| June 30, 2016 | -4.80K% |
| March 31, 2016 | -1.58K% |
| December 31, 2015 | -1.76K% |
| September 30, 2015 | -85.13% |
| June 30, 2015 | -934.2% |
| March 31, 2015 | -1.07K% |
| December 31, 2014 | -1.07K% |
| September 30, 2014 | -596.0% |
| June 30, 2014 | -1.09K% |
| March 31, 2014 | -1.03K% |
| December 31, 2013 | -11.18K% |
| September 30, 2013 | -4.04K% |
| June 30, 2013 | -3.34K% |
| March 31, 2013 | -1.88K% |
| December 31, 2012 | -1.44K% |
| September 30, 2012 | -922.8% |
| June 30, 2012 | -434.3% |
| March 31, 2012 | -822.6% |
| December 31, 2011 | -595.8% |
| September 30, 2011 | -765.4% |
| June 30, 2011 | -1.47K% |
| March 31, 2011 | -290.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.91K%
Minimum
Jun 2022
17.61%
Maximum
Mar 2021
-847.2%
Average
-859.1%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Scilex Holding Co | -159.0% |
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -103.9% |
| Return on Invested Capital | -794.4% |
| Gross Profit Margin (Quarterly) | 43.74% |
| Operating Margin (Quarterly) | -510.9% |
| Return on Net Operating Assets | -136.1% |